Roche Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Roche key operating metrics including New Molecular Entities in Clinical Development, environmental, and social and governance score (ESG).

New Molecular Entities in Clinical Development

5.7%

FY, 2023

Patients Included in Clinical Trials

303.9K

13.6%

FY, 2023

Tests Conducted (Diagnostics Products)

29.2B

FY, 2023

Operating Metrics

Metrics	FY, 2021	FY, 2022	FY, 2023
New Molecular Entities in Clinical Development	80	87	82
Patients Included in Clinical Trials	244.5K	267.4K	303.9K
Tests Conducted (Diagnostics Products)	27B	29B	29.2B
Patients Treated with Off-Patent Medicines	15M	11.7M	18M
Patients Treated with Patent Medicines	1.4M	2.6M	4.8M
Major Regulatory Filings (Pharmaceuticals)	16	10	9
US FDA Breakthrough Therapy Designations	2	1
New Medicines Launched	3	2	2
Key Products Launched (Diagnostics)	16	15	15
Patients	16.4M	14.2M	22.8M

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub